Jay Zaveri
Founder and Partner @ Natural Capital
San Francisco Bay Area, United States
Jay Zaveri is a seed investor at Natural Capital in San Francisco Bay Area focused on Health Care and Biotechnology. Jay Zaveri is based out of Menlo Park, California, and is the President and Board of Directors of Aether Bio and Founder and Partner of Natural Capital.
- Total investments:
- 70
- Last investment:
- Lead investor:
- 27%
Last updated:
For AI agents: llms.txt
Industries Jay Zaveri invests in
Stages Jay Zaveri invests in
Countries Jay Zaveri invests in
Round sizes
Round size
- Seed
- $1M–$4M
- Series A
- $3M–$25M
- Series B
- $25M–$6B
Investment Focus
Industry
- Health Care 10 (14%)
- Biotechnology 10 (14%)
- Artificial Intelligence 9 (13%)
- Software 7 (10%)
- Information Technology 6 (9%)
Stage
- Seed 25 (36%)
- Series A 13 (19%)
- Series B 8 (11%)
- Funding Round 8 (11%)
- Venture - Series Unknown 4 (6%)
Country
- United States 42 (60%)
- Japan 1 (1%)
- Canada 1 (1%)
- Latvia 1 (1%)
- Nigeria 1 (1%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
Odyssey
|
Odyssey operates as an AI start-up, provides hollywood-grade visual AI. | $310M / Series B / Jun 17, 2026 | |
Xona
|
Xona Space Systems is building a next-generation satellite navigation system using small but powerful satellites in low-Earth orbit. The constellation they are developing is designed to provide secure navigation and timing services with the resilience and accuracy that modern intelligent systems, such as autonomous vehicles and drones, need tooperate safely at scale. | $170M / Series C / Mar 26, 2026 | |
Aether Bio
|
Aether Bio is a developer of machine learning technology used to repurpose enzymes in order to create new compounds. Its technology utilizes machine learning combined with high-throughput robotic laboratories to create an entirely new compound and reinvent the production of previously discovered compounds that enable healthcare institutes to getthe chemicals and materials they need that are cheaper and more sustainable. The company's proprietary hardware allows massively parallelized experimentation, generating datasets orders of magnitude larger than the competition. | $15M / Venture - Series Unknown / Dec 03, 2025 | |
ZeroBrush
|
ZeroBrush is a healthcare service company. | $10.8M / Series A / Sep 09, 2025 | |
xAI
|
XAI is an AI company that develops a platform to accelerate human scientific discovery. The company primarily focuses on developing advanced AI systems that are truthful, competent, and maximally beneficial for all of humanity. Its mission is to understand the true nature of the universe. | $5.3B / Venture - Series Unknown / Jul 13, 2025 | |
Ashvattha Therapeutics
|
Ashvattha Therapeutics creates products that selectively target and treat human diseases. Ashvattha enables precision targeting for therapeutics eliminating off-target toxicity, systemic side effects, and immunogenicity seen in other platforms. Ashvattha has a pipeline of nine therapeutics in neurology, oncology, and ophthalmology. | $50M / Series B / Jan 13, 2025 | |
|
xAI
|
XAI is an AI company that develops a platform to accelerate human scientific discovery. The company primarily focuses on developing advanced AI systems that are truthful, competent, and maximally beneficial for all of humanity. Its mission is to understand the true nature of the universe. | $6B / Series B / May 26, 2024 | |
Tierra Biosciences
|
Tierra Biosciences is a synthetic biology company that accelerates the pace of discovery and enables the next generation of bio-based materials. Tierra’s first product, the Tierra Protein Platform, couples high-throughput protein manufacturing with the simplicity of e-commerce to make ordering custom proteins easier than ever before. By loweringthe traditional protein synthesis barrier, Tierra serves scientists looking to change the world with novel proteins. Led by a team of protein experts, this fast-growing company is transforming the way people discover, screen, and develop proteins for future bio-based products. For more information, visit tierrabiosciences.com. | $11.4M / Series A / Mar 12, 2024 | |
|
Aether Bio
|
Aether Bio is a developer of machine learning technology used to repurpose enzymes in order to create new compounds. Its technology utilizes machine learning combined with high-throughput robotic laboratories to create an entirely new compound and reinvent the production of previously discovered compounds that enable healthcare institutes to getthe chemicals and materials they need that are cheaper and more sustainable. The company's proprietary hardware allows massively parallelized experimentation, generating datasets orders of magnitude larger than the competition. | $49M / Series A / Aug 16, 2023 | |
SpaceX
|
Space Exploration Technologies is a space-transportation startup company founded by Elon Musk. SpaceX designs, manufactures, and launches advanced rockets and spacecraft. SpaceX develops crew and cargo capsules, engines, cryogenic tank structures, avionics, equipment, guidance, and control software. The company is developing the partially reusablelaunch vehicles Falcon 1 and Falcon 9.Founded in 2002, Space Exploration Technologies is headquartered in Hawthorne, California. | $750M / Private Equity / Jan 02, 2023 | |
| See all 70 investments → | |||
Co-Investors
About Natural Capital
Solving the world's hardest problems by bringing capital, technology and people together.
Natural Capital Contacts
| Name | Phone | Socials | |
|---|---|---|---|
|
Jay Zaveri
Founder and Partner
|
|||
Ravi Tanuku
Managing General Partner
|
|||
3 more contacts available
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar industry
Featured in Investor Lists
Recommended lists
FAQ
What does Jay Zaveri invest in?
Jay Zaveri invests primarily in Health Care, Biotechnology and Artificial Intelligence startups, most often at Seed and Series A stage. Most of the 70 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.
What is Jay Zaveri's check size?
Jay Zaveri typically joins rounds of $1M–$4M at Seed, $3M–$25M at Series A and $25M–$6B at Series B. These ranges are 10th–90th percentile round sizes calculated from confirmed public funding rounds, so they are a realistic guide to the rounds Jay Zaveri participates in.
When did Jay Zaveri last invest?
The most recent investment recorded for Jay Zaveri closed in Jun 2026. Shizune tracks 70 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
